Gilead Sciences
GILD
2,215 hedge funds and large institutions have $137B invested in Gilead Sciences in 2025 Q4 according to their latest regulatory filings, with 334 funds opening new positions, 879 increasing their positions, 736 reducing their positions, and 109 closing their positions.
206% more first-time investments, than exits
New positions opened: 334 | Existing positions closed: 109
47% more funds holding in top 10
Funds holding in top 10: 19 → 28 (+9)
19% more repeat investments, than reductions
Existing positions increased: 879 | Existing positions reduced: 736
17% more capital invested
Capital invested by funds: $117B → $137B (+$20B)
9% more funds holding
Funds holding: 2,026 → 2,215 (+189)
5.13% more ownership
Funds ownership: 85.16% → 90.29% (+5.1%)
8% more call options, than puts
Call options by funds: $916M | Put options by funds: $852M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$3.44B |
| 2 |
BlackRock
New York
|
+$840M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$640M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$513M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$500M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.18B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$572M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$468M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$392M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$336M |
GILD Hedge Fund Activity: Q4 2025 in Review
2,215 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2025, worth a combined $137B — up 17% from $117B a quarter earlier.
Buyers outnumbered sellers: 334 funds opened new GILD positions and 109 closed out — a net gain of 225 holders — while 879 added to existing stakes and 736 trimmed.
The largest buyer was Invesco, adding an estimated $3.44B. The largest seller was Wellington Management Group, cutting an estimated $1.18B.
- 2,215 institutional investors held Gilead Sciences (GILD) as of Q4 2025, up from 2,026 in Q3 2025.
- Funds reported $137B of Gilead Sciences stock for Q4 2025, up 17% quarter-over-quarter.
- 334 funds opened new Gilead Sciences positions in Q4 2025 and 109 closed out, a net change of +225 holders.
- The largest Gilead Sciences buyer in Q4 2025 was Invesco, an estimated $3.44B added.
- The largest Gilead Sciences seller in Q4 2025 was Wellington Management Group, an estimated $1.18B sold.
Based on aggregated 13F filings for Q4 2025.